Currently out of the existing stock ratings of David Turkaly, 189 are a BUY (92.2%), 15 are a HOLD (7.32%), 1 are a SELL (0.49%).

David Turkaly

Work Performance Price Targets & Ratings Chart

Analyst David Turkaly, carries an average stock price target met ratio of 35.14% that have a potential upside of 26.95% achieved within 236 days.

David Turkaly’s has documented 392 price targets and ratings displayed on 22 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on LNTH, Lantheus Holdings at 29-Jun-2026.

Wall Street Analyst David Turkaly

Analyst best performing recommendations are on NVTR (NUVECTRA).
The best stock recommendation documented was for LNTH (LANTHEUS HOLDINGS) at 2/24/2026. The price target of $78 was fulfilled within 7 days with a profit of $4.39 (5.96%) receiving and performance score of 8.52.

Average potential price target upside

of $63.71 (19.59%) on TFX (TELEFLEX).
of $38.01 (20.58%) on STE (STERIS PLC).
of $28.58 (26.26%) on ZBH (ZIMMER BIOMET HOLDINGS).

APYX Apyx Medical AXGN Axogen HAE Haemonetics IART Integra LifeSciences Holdings KIDS Orthopediatrics Corp NVRO Nevro Corp SRGA Surgalign Holdings STE STERIS plc STIM Neuronetics TFX Teleflex ZBH Zimmer Biomet Holdings SIBN Si-Bone FNA Paragon 28 ICAD icad inc NVTR Nuvectra TELA Tela Bio GMED Globus Medical LNTH Lantheus Holdings AVNS Avanos Medical ENOV Enovis Corp OFIX Orthofix Medical SYK Stryker

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matt Hewitt (CRAIG HALLUM)